FACTX — Fidelity Advisor Health Care Fund
Data updated: 2026-06-26
FACTX — Fidelity Advisor Health Care Fund. United States Multi-Cap / All-Cap Growth Health Care Equity. Holdings, fees, performance and SEC filings.
FACTX Fund Overview
FACTX — Fidelity Advisor Health Care Fund is a US mutual fund managed by Fidelity Advisor Series VII, categorised as United States Multi-Cap / All-Cap Growth Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Fidelity Advisor Series VII
- Category: United States Multi-Cap / All-Cap Growth Health Care Equity
- Assets under management: $2.89B
- 1-year return: 10.9%
- Ticker: FACTX
- SEC CIK: 0000315700
- SEC series ID: S000005329
- Share class ID: C000014562
FACTX Holdings
Top 10 holdings of Fidelity Advisor Health Care Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| ELI LILLY and CO | 6.93% |
| Danaher Corp. | 6.79% |
| JOHNSON and JOHNSON | 5.67% |
| Thermo Fisher Scientific, Inc. | 3.62% |
| Unitedhealth Group, Inc. | 3.02% |
| Boston Scientific Corp. | 2.79% |
| Ascendis Pharma A/s | 2.70% |
| Alnylam Pharmaceuticals, Inc. | 2.44% |
| Gilead Sciences, Inc. | 2.27% |
| Abbvie, Inc. | 2.23% |
FACTX Portfolio Allocation
Asset-class allocation of Fidelity Advisor Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 1.5% |
| Fixed Income | 0.2% |
FACTX Performance
Total returns for FACTX (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -4.9% |
| 1 year | 10.9% |
| 3 years (annualised) | -20.0% |
| 5 years (annualised) | -27.2% |
FACTX Risk Information
Risk metrics for FACTX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 14.3%
FACTX Costs and Fees
FACTX costs about $118 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.18%
- Gross expense ratio: 1.18%
- Portfolio turnover: 52%
- Brokerage commissions: 2.58 bps of average net assets (SEC N-CEN)
FACTX Cashflows
Over the 12 months to 2026-04, Fidelity Advisor Health Care Fund had net outflows of $652.68M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-04 | −$68.08M |
| 2026-03 | −$52.60M |
| 2026-02 | −$86.52M |
| 2026-01 | −$62.01M |
| 2025-12 | $282.88M |
| 2025-11 | −$53.27M |
FACTX Debt Constituents
Largest debt holdings of Fidelity Advisor Health Care Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Kardium Inc/us | 0.10% |
| Wugen, Inc. | 0.05% |
| Galvanize Therapeutics | 0.03% |
FACTX Prospectus and SEC Filings
Official Fidelity Advisor Health Care Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2025-09-24
- Prospectus (485BPOS) — filed 2024-09-24
- Prospectus supplement (497) — filed 2024-03-01
- Portfolio holdings (N-PORT) — filed 2026-06-26
- Portfolio holdings (N-PORT) — filed 2026-03-25
- Portfolio holdings (N-PORT) — filed 2025-12-23
- Annual census (N-CEN) — filed 2025-10-14
- Annual census (N-CEN) — filed 2024-10-15
Related Funds
Other United States Multi-Cap / All-Cap Growth Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.